Christopher L. Amling MD, FACSJohn Barry Professor and Chair, Department of Urology, Oregon Health & Science University, Portland, Oregon
Dr. Christopher L. Amling, FACS, is the John Barry Professor and Chair of the Department of Urology at Oregon Health & Science University (OHSU) and also serves as the Director of Robotic Surgery for the OHSU Health System. He received his undergraduate education from the University of Oregon and his medical degree from OHSU. He did his surgery and urology residency training at Duke University Medical Center and then completed a fellowship in urologic oncology at the Mayo Clinic. Dr. Amling served in the US Navy for 20 years, attaining the rank of Captain. Before coming to OHSU in 2009, he was Program Director and Chair of Urology at the Naval Medical Center in San Diego and then Chief of the Division of Urology at the University of Alabama at Birmingham.
Dr. Amling has a longtime interest in resident training and experience in the development and assessment of resident evaluation tools. In collaboration with the ACGME, he developed the SECR resident competency evaluation system in 2001 which was made available via the ACGME website to program directors of all specialties. He served on the Urology Residency Review Committee (RRC) for six years and has been a member of other national committees related to resident education including the ACGME Urology Milestones Project Committee and the ACGME Advisory Committee on Education Outcome Assessment. Dr. Amling was Chair of the Fellowship Committee for the Society of Urologic Oncology and also served as President of the Society of University Urologists in 2009.
Dr. Amling has been on several national AUA committees including the Education Council, Research Council and the Public Media Committee, and is the recipient of the AUA Gold Cystoscope Award in 2009. He has served on the Board of Directors for both the WSAUA and SESAUA and was President of the WSAUA in 2020. He is a member of multiple professional organizations including the American Surgical Association (ASA), the Western Urologic Forum (WUF), the American Association of Genitourinary Surgeons (AAGUS) and the Clinical Society of Genitourinary Surgeons (CSGUS). Dr. Amling has contributed over 250 peer-reviewed publications, most of which have focused on prostate cancer risk assessment and treatment outcomes. His clinical practice focuses on the utilization of robotic and minimally invasive surgery for the treatment of genitourinary malignancies.
Recent Contributions to PracticeUpdate:
- Robot-Assisted PSMA-Radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe
- Radical Prostatectomy vs Radiation in High-Risk and Very High-Risk Prostate Cancer
- Impact of Pretransplant Malignancy on Outcomes After Kidney Transplantation
- Analysis of Robot-Assisted Versus Laparoscopic Live Donor Nephrectomy
- No Benefit and Higher Costs Associated With Robot-Assisted Live Donor Nephrectomy